Multifunctional nanobeacon for imaging Thomsen-Friedenreich antigen-associated colorectal cancer

International Journal of Cancer

Volumn 132, Issue 9, 2013, Pages 2107-2117

  Kumagai, Hironori ^a,b   Pham, Wellington ^a,c,d,e   Kataoka, Makoto ^a,f   Hiwatari, Ken Ichiro ^b   McBride, James ^a   Wilson, Kevin J ^a   Tachikawa, Hiroyuki ^b   Kimura, Ryoji ^b   Nakamura, Kunio ^b   Liu, Eric H ^e   Gore, John C ^a,c,d,e   Sakuma, Shinji ^f  

^a VANDERBILT UNIVERSITY   (United States)

^b ADEKA CORPORATION   (Japan)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SETSUNAN UNIVERSITY   (Japan)

Author keywords

agglutinin; colorectal cancer; diagnosis; molecular imaging; nanotechnology; optical imaging; polymer; targeted imaging; Thomsen Friedenreich antigen

Indexed keywords

BIOLOGICAL MARKER; NANOBEACON; NANOSPHERE; PEANUT AGGLUTININ; SUBMICRON-SIZED POLYSTYRENE NANOSPHERE; THOMSEN-FRIEDENREICH ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL TUMOR; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTESTINE LOOP; LARGE INTESTINE; MALE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; COUMARINS; DIAGNOSTIC IMAGING; FLUORESCENT DYES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, TRANSGENIC; NANOSPHERES; PEANUT AGGLUTININ; POLYSTYRENES; REAL-TIME POLYMERASE CHAIN REACTION; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURFACE PROPERTIES; THIAZOLES; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 84874038578     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27903     Document Type: Article

References (33)

1. Daley D, Lewis S, Platzer P, et al. Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling study. Am J Hum Genet 2008; 82: 723-36.
2. Fahy B, Bold RJ,. Epidemiology and molecular genetics of colorectal cancer. Surg Oncol 1998; 7: 115-23.
3. Saito H,. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan. J Med Screen 2006; 13: S6-S7.
4. Ortega J, Vigil CE, Chodkiewicz C,. Current progress in targeted therapy for colorectal cancer. Cancer Control 2010; 17: 7-15.
5. Sheth RA, Mahmood U,. Optical molecular imaging and its emerging role in colorectal cancer. Am J Physiol Gastrointest Liver Physiol 2010; 299: G807-20.
6. Kelly K, Alencar H, Funovics M, et al. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res 2004; 64: 6247-51.
7. Hsiung PL, Hardy J, Friedland S, et al. Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat Med 2008; 14: 454-8.
8. Yuan M, Itzkowitz SH, Boland CR, et al. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Cancer Res 1986; 46: 4841-7.
9. Rosenberg WM, Prince C, Kaklamanis L, et al. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 1995; 345: 1205-9.
10. Singh R, Campbell BJ, Yu LG, et al. Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44. Glycobiology 2001; 11: 587-92.
11. Yuan M, Itkowitz SH, Boland CR, et al. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Cancer Res 1986; 46: 4841-7.
12. Bray J, MacLean GD, Dusel FJ, et al. Decreased levels of circulating lytic anti-T in The serum of patients with metastatic gastrointestinal cancer: a correlation with disease burden. Clin Exp Immunol 1982; 47: 176-82.
13. Ryder SD, Smith JA, Rhodes JM,. Peanut lectin: a mitogen for normal human colonic epithelium and human HT29 colorectal cancer cells. J Natl Cancer Inst 1992; 84: 1410-6.
14. Boland CR, Roberts JA,. Quantitation of lectin binding sites in human colon mucins by use of peanut and wheat germ agglutinins. J Histochem Cytochem 1988; 36: 1305-7.
15. Boland CR, Montgomery CK, Kim YS,. A cancer-associated mucin alteration in benign colonic polyps. Gastroenterology 1982; 82: 664-72.
16. Rhodes JM, Black RR, Savage A,. Glycoprotein abnormalities in colonic carcinomata, adenomata, and hyperplastic polyps shown by lectin peroxidase histochemistry. J Clin Pathol 1986; 39: 1331-4.
17. McEwan AJ, MacLean GD, Hooper HR, et al. MAb 170H.82: an evaluation of a novel panadenocarcinoma monoclonal antibody labelled with 99Tcm and with 111In. Nucl Med Commun 1992; 13: 11-19.
18. Sakuma S, Sudo R, Suzuki N, et al. Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine. J Control Release 2002; 81: 281-90.
19. Sakuma S, Hayashi M, Akashi M,. Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv Drug Deliv Rev 2001; 47: 21-37.
20. Sakuma S, Sudo R, Suzuki N, et al. Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract. Int J Pharm 1999; 177: 161-72.
21. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25: 402-8.
22. Steuden I, Duk M, Czerwinski M, et al. The monoclonal antibody, anti-asialoglycophorin from human erythrocytes, specific for -D-Gal-I-3-c -D-GalNAc-chains (Thomsen-Friedenreich receptors). Glycoconjugate J 1985; 2: 303-14.
23. Cao Y, Karsten UR, Liebrich W, et al. Expression of Thomsen-Friedenreich- related antigens in primary and metastatic colorectal carcinomas. A reevaluation. Cancer 1995; 76: 1700-8.
24. Nemoto-Sasaki Y, Mitsuki M, Morimoto-Tomita M, et al. Correlation between the sialylation of cell surface Thomsen-Friedenreich antigen and the metastatic potential of colon carcinoma cells in a mouse model. Glycoconjugate J 2001; 18: 895-906.
25. Itzkowitz SH, Yuan M, Montgomery CK, et al. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 1989; 49: 197-204.
26. Brockhausen I, Schutzbach J, Kuhns W,. Glycoproteins and their relationship to human disease. Acta Anat (Basel) 1998; 161: 36-78.
27. Springer GF,. T and Tn, general carcinoma autoantigens. Science 1984; 224: 1198-206.
28. Springer GF, Desai PR, Wise W, et al. Pancarcinoma T and Tn epitopes: autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis. Immunol Ser 1990; 53: 587-612.
29. Moriyama H, Nakano H, Igawa M, et al. T antigen expression in benign hyperplasia and adenocarcinoma of the prostate. Urol Int 1987; 42: 120-3.
30. Wolf MF, Ludwig A, Fritz P, et al. Increased expression of Thomsen-Friedenreich antigens during tumor progression in breast cancer patients. Tumour Biol 1988; 9: 190-4.
31. Xu Y, Sette A, Sidney J, et al. Tumor-associated carbohydrate antigens: a possible avenue for cancer prevention. Immunol Cell Biol 2005; 83: 440-8.
32. Xu Y, Gendler SJ, Franco A,. Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas. J Exp Med 2004; 199: 707-16.
33. Jeschke U, Walzel H, Mylonas I, et al. The human endometrium expresses the glycoprotein mucin-1 and shows positive correlation for Thomsen-Friedenreich epitope expression and galectin-1 binding. J Histochem Cytochem 2009; 57: 871-81.